Major cable and broadcast news outlets seem to have largely ignored a Wall Street Journal report that Donald Trump Jr. stands to potentially benefit financially from a deal between BlinkRx and the government-run TrumpRx pharmaceutical program. Apparently, neither The New York Times or The Washington Post covered the Journal’s findings either.
Everything he wants it on Everything, not understanding the moment hes dead at the very least it all goes back… I guess he won’t care at that point…